NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球促血紅細胞生長素製劑市場:產業分析與預測 - 各醫藥品分類、產品、用途、地區(2021年∼2027年)

Global Erythropoietin Drugs Market By Drug Class, By Product, By Application, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

出版商 KBV Research 商品編碼 1015884
出版日期 內容資訊 英文 195 Pages
訂單完成後即時交付
價格
全球促血紅細胞生長素製劑市場:產業分析與預測 - 各醫藥品分類、產品、用途、地區(2021年∼2027年) Global Erythropoietin Drugs Market By Drug Class, By Product, By Application, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027
出版日期: 2021年06月15日內容資訊: 英文 195 Pages
簡介

促血紅細胞生長素(EPO),是又稱紅細胞生成素的糖蛋白質荷爾蒙的一種。促血紅細胞生長素,開發以治療末期腎功能衰竭造成的貧血,有助於腎功能衰竭治療和透析療法。全球促血紅細胞生長素製劑的市場規模,預計在預測期間中以11.8%的年複合成長率成長,至2027年達到202億美元。

本報告提供全球促血紅細胞生長素製劑市場調查,市場概要,各醫藥品分類、產品、用途、地區的市場規模的變化與預測,新型冠狀病毒感染疾病(COVID-19)的影響分析,市場成長要素,被實行的市場策略,近幾年的產業趨勢,主要企業簡介等彙整資訊。

目錄

第1章 市場範圍與調查手法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 全球促血紅細胞生長素製劑市場:各醫藥品分類

  • 生物製劑
  • 生物相似藥

第4章 全球促血紅細胞生長素製劑市場:各產品

  • 紅血球生成素Alpha
  • 紅血球生成素β
  • Darbepoetin-alfa
  • 其他

第5章 全球促血紅細胞生長素製劑市場:各用途

  • 腎臟疾病
  • 腫瘤
  • 血液疾病
  • 神經疾病

第6章 全球促血紅細胞生長素製劑市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第7章 企業簡介

  • Johnson and Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Biocon Limited
  • Intas Pharmaceutical Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • LG Corporation(LG Life Sciences Ltd.)
  • Celltrion, Inc.
目錄

The Global Erythropoietin Drugs Market size is expected to reach $20.2 billion by 2027, rising at a market growth of 11.8% CAGR during the forecast period. Erythropoietin (EPO) also called hematopoietin is a glycoprotein hormone. It stimulates the process of erythropoiesis which results in the production of red blood cells in the bone marrow. The main goal for the development of erythropoietin drug was to treat anaemic conditions arising from end-stage renal disease (ESRD) disease. Thus, it helps in treatments of this disease and dialysis procedures. Apart from its use in ESRD anaemic conditions, erythropoietin drugs also received approvals for chemotherapy-induced anaemia. The post-abbreviated new drug application (ANDA) is getting approvals and there is a high success rate of erythropoietin drugs in chemotherapy-induced anaemia. Due to all these factors, major biopharmaceutical companies turned their focus towards another form of induced anaemia, that is ART-induced anaemia which occurs mostly among the HIV patients.

Epoetin alfa (Epoge) is a kind of recombinant erythropoietin that was developed by Amgen Inc. in 1983. It was the first rhEPO that was commercialized in the United States, after alfa and beta formulations. Epoetin refers to an erythropoiesis-stimulating glycoprotein that is composed of a 165-amino acid. It is produced in cell culture based on recombinant DNA technology. This drug is used to treat patients suffering from anaemia and other blood-related clinical conditions like chronic renal failure, chemotherapy, and antiviral drug therapy. This drug is also recommended for patients who are at high risk for perioperative blood loss due to surgical procedures.

COVID-19 Impact

The COVID-19 resulted in the disruption of workflows in the health care sector across the world. A number of industries were forced to go for shutdown temporarily due to this outbreak. The main affected industry is the sub-domains of health care. Yet, it has positively affected the demand for medicines and increased the demand for several medical services, such as erythropoietin. The erythropoietin (EPO) drug is used to treat anaemia and works effectively against COVID-19. This has been scientifically proved by scientists of the Max Planck Institute of Experimental Medicine in Gottingen. According to the research, the SARS-CoV-2 potentially attacks the brain, and erythropoietin can diminish serious disease development. Thus, it can protect people from the development of long-term neurological problems.

However, EPO is beneficial in many other diseases and has cytoprotective effects such as regenerative, anti-ischemic, and anti-apoptotic effects in tissues like lung, kidney, cardiac muscle, retina, pancreas, nervous system, and endothelial cells. Therefore, the impact of the COVID-19 pandemic is likely to have a positive impact on the erythropoietin drug market.

Drug Class Outlook

Based on Drug Class, the market is segmented into Biologics and Biosimilars. Based on Drug Class, the biologics erythropoietin segment dominated the market in 2020 because of the patent protection. Other factors driving the growth of this segment include the presence of a large patient population and increased uptake of biologics in various diseases. The availability of very few biologics in the market resulted in higher adoption of this drug.

Product Outlook

Based on Product, the market is segmented into Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and others. Epoetin-beta is a recombinant type of drug formed from epoetin-alfa. This product segment is growing owing to its benefits like improved efficacy and a longer half-life compared to the epoetin-alfa. Darbepoetin-alfa is also a novel erythropoietin drug. It is developed by Amgen, Inc., marketed under the brand name Aranesp. Darbepoetin-alfa segment is likely to see positive growth during the forecast period. It is accredited to its higher efficacy, cost-effectiveness, and longer half-life. It is considered a feasible solution for the treatment of anaemia arising due to end-stage renal diseases.

Application Outlook

Based on Application, the market is segmented into Renal Diseases, Cancer, Hematology and Neurology. The cancer segment would showcase fastest growth rate during the forecast period. It is due to the increasing cases of cancer incidence across the world. Cancer chemotherapy includes the utilization of medication which is capable of increasing the RBC count amongst patients. Thus, the usage of such drugs for chemotherapy has gained considerable attention in recent years. This has increased the demand for EPO drugs for cancer treatment that will act as a positive factor to augment the growth of this segment.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as one of the dominating regions of the global market by. It is accredited to the factors like the increasing incidence of chronic diseases including cancer, CKD, and HIV. As per data by the Centers for Disease Control and Prevention (CDC), there are 1.2 million people in the U.S. who are living with HIV and more than 39,000 cases were detected in 2015. These statistics are a clear indication that the demand for EPO drugs will increase over the forecast period.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., F. Hoffmann-La Roche Ltd., Biocon Limited, Intas Pharmaceutical Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., LG Corporation (LG Life Sciences Ltd.), and Celltrion, Inc.

Scope of the Study

Market Segments covered in the Report:

By Drug Class

  • Biologics
  • Biosimilars

By Product

  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • others

By Application

  • Renal Diseases
  • Cancer
  • Hematology
  • Neurology

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Johnson and Johnson
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Biocon Limited
  • Intas Pharmaceutical Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • LG Corporation (LG Life Sciences Ltd.)
  • Celltrion, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Erythropoietin Drugs Market, by Drug Class
    • 1.4.2 Global Erythropoietin Drugs Market, by Product
    • 1.4.3 Global Erythropoietin Drugs Market, by Application
    • 1.4.4 Global Erythropoietin Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market composition and scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Erythropoietin Drugs Market by Drug Class

  • 3.1 Global Biologics Market by Region
  • 3.2 Global Biosimilars Market by Region

Chapter 4. Global Erythropoietin Drugs Market by Product

  • 4.1 Global Epoetin-alfa Market by Region
  • 4.2 Global Epoetin-beta Market by Region
  • 4.3 Global Darbepoetin-alfa Market by Region
  • 4.4 Global Other Product Market by Region

Chapter 5. Global Erythropoietin Drugs Market by Application

  • 5.1 Global Renal Diseases Market by Region
  • 5.2 Global Cancer Market by Region
  • 5.3 Global Hematology Market by Region
  • 5.4 Global Neurology Market by Region

Chapter 6. Global Erythropoietin Drugs Market by Region

  • 6.1 North America Erythropoietin Drugs Market
    • 6.1.1 North America Erythropoietin Drugs Market by Drug Class
      • 6.1.1.1 North America Biologics Market by Country
      • 6.1.1.2 North America Biosimilars Market by Country
    • 6.1.2 North America Erythropoietin Drugs Market by Product
      • 6.1.2.1 North America Epoetin-alfa Market by Country
      • 6.1.2.2 North America Epoetin-beta Market by Country
      • 6.1.2.3 North America Darbepoetin-alfa Market by Country
      • 6.1.2.4 North America Other Product Market by Country
    • 6.1.3 North America Erythropoietin Drugs Market by Application
      • 6.1.3.1 North America Renal Diseases Market by Country
      • 6.1.3.2 North America Cancer Market by Country
      • 6.1.3.3 North America Hematology Market by Country
      • 6.1.3.4 North America Neurology Market by Country
    • 6.1.4 North America Erythropoietin Drugs Market by Country
      • 6.1.4.1 US Erythropoietin Drugs Market
        • 6.1.4.1.1 US Erythropoietin Drugs Market by Drug Class
        • 6.1.4.1.2 US Erythropoietin Drugs Market by Product
        • 6.1.4.1.3 US Erythropoietin Drugs Market by Application
      • 6.1.4.2 Canada Erythropoietin Drugs Market
        • 6.1.4.2.1 Canada Erythropoietin Drugs Market by Drug Class
        • 6.1.4.2.2 Canada Erythropoietin Drugs Market by Product
        • 6.1.4.2.3 Canada Erythropoietin Drugs Market by Application
      • 6.1.4.3 Mexico Erythropoietin Drugs Market
        • 6.1.4.3.1 Mexico Erythropoietin Drugs Market by Drug Class
        • 6.1.4.3.2 Mexico Erythropoietin Drugs Market by Product
        • 6.1.4.3.3 Mexico Erythropoietin Drugs Market by Application
      • 6.1.4.4 Rest of North America Erythropoietin Drugs Market
        • 6.1.4.4.1 Rest of North America Erythropoietin Drugs Market by Drug Class
        • 6.1.4.4.2 Rest of North America Erythropoietin Drugs Market by Product
        • 6.1.4.4.3 Rest of North America Erythropoietin Drugs Market by Application
  • 6.2 Europe Erythropoietin Drugs Market
    • 6.2.1 Europe Erythropoietin Drugs Market by Drug Class
      • 6.2.1.1 Europe Biologics Market by Country
      • 6.2.1.2 Europe Biosimilars Market by Country
    • 6.2.2 Europe Erythropoietin Drugs Market by Product
      • 6.2.2.1 Europe Epoetin-alfa Market by Country
      • 6.2.2.2 Europe Epoetin-beta Market by Country
      • 6.2.2.3 Europe Darbepoetin-alfa Market by Country
      • 6.2.2.4 Europe Other Product Market by Country
    • 6.2.3 Europe Erythropoietin Drugs Market by Application
      • 6.2.3.1 Europe Renal Diseases Market by Country
      • 6.2.3.2 Europe Cancer Market by Country
      • 6.2.3.3 Europe Hematology Market by Country
      • 6.2.3.4 Europe Neurology Market by Country
    • 6.2.4 Europe Erythropoietin Drugs Market by Country
      • 6.2.4.1 Germany Erythropoietin Drugs Market
        • 6.2.4.1.1 Germany Erythropoietin Drugs Market by Drug Class
        • 6.2.4.1.2 Germany Erythropoietin Drugs Market by Product
        • 6.2.4.1.3 Germany Erythropoietin Drugs Market by Application
      • 6.2.4.2 UK Erythropoietin Drugs Market
        • 6.2.4.2.1 UK Erythropoietin Drugs Market by Drug Class
        • 6.2.4.2.2 UK Erythropoietin Drugs Market by Product
        • 6.2.4.2.3 UK Erythropoietin Drugs Market by Application
      • 6.2.4.3 France Erythropoietin Drugs Market
        • 6.2.4.3.1 France Erythropoietin Drugs Market by Drug Class
        • 6.2.4.3.2 France Erythropoietin Drugs Market by Product
        • 6.2.4.3.3 France Erythropoietin Drugs Market by Application
      • 6.2.4.4 Russia Erythropoietin Drugs Market
        • 6.2.4.4.1 Russia Erythropoietin Drugs Market by Drug Class
        • 6.2.4.4.2 Russia Erythropoietin Drugs Market by Product
        • 6.2.4.4.3 Russia Erythropoietin Drugs Market by Application
      • 6.2.4.5 Spain Erythropoietin Drugs Market
        • 6.2.4.5.1 Spain Erythropoietin Drugs Market by Drug Class
        • 6.2.4.5.2 Spain Erythropoietin Drugs Market by Product
        • 6.2.4.5.3 Spain Erythropoietin Drugs Market by Application
      • 6.2.4.6 Italy Erythropoietin Drugs Market
        • 6.2.4.6.1 Italy Erythropoietin Drugs Market by Drug Class
        • 6.2.4.6.2 Italy Erythropoietin Drugs Market by Product
        • 6.2.4.6.3 Italy Erythropoietin Drugs Market by Application
      • 6.2.4.7 Rest of Europe Erythropoietin Drugs Market
        • 6.2.4.7.1 Rest of Europe Erythropoietin Drugs Market by Drug Class
        • 6.2.4.7.2 Rest of Europe Erythropoietin Drugs Market by Product
        • 6.2.4.7.3 Rest of Europe Erythropoietin Drugs Market by Application
  • 6.3 Asia Pacific Erythropoietin Drugs Market
    • 6.3.1 Asia Pacific Erythropoietin Drugs Market by Drug Class
      • 6.3.1.1 Asia Pacific Biologics Market by Country
      • 6.3.1.2 Asia Pacific Biosimilars Market by Country
    • 6.3.2 Asia Pacific Erythropoietin Drugs Market by Product
      • 6.3.2.1 Asia Pacific Epoetin-alfa Market by Country
      • 6.3.2.2 Asia Pacific Epoetin-beta Market by Country
      • 6.3.2.3 Asia Pacific Darbepoetin-alfa Market by Country
      • 6.3.2.4 Asia Pacific Other Product Market by Country
    • 6.3.3 Asia Pacific Erythropoietin Drugs Market by Application
      • 6.3.3.1 Asia Pacific Renal Diseases Market by Country
      • 6.3.3.2 Asia Pacific Cancer Market by Country
      • 6.3.3.3 Asia Pacific Hematology Market by Country
      • 6.3.3.4 Asia Pacific Neurology Market by Country
    • 6.3.4 Asia Pacific Erythropoietin Drugs Market by Country
      • 6.3.4.1 China Erythropoietin Drugs Market
        • 6.3.4.1.1 China Erythropoietin Drugs Market by Drug Class
        • 6.3.4.1.2 China Erythropoietin Drugs Market by Product
        • 6.3.4.1.3 China Erythropoietin Drugs Market by Application
      • 6.3.4.2 Japan Erythropoietin Drugs Market
        • 6.3.4.2.1 Japan Erythropoietin Drugs Market by Drug Class
        • 6.3.4.2.2 Japan Erythropoietin Drugs Market by Product
        • 6.3.4.2.3 Japan Erythropoietin Drugs Market by Application
      • 6.3.4.3 India Erythropoietin Drugs Market
        • 6.3.4.3.1 India Erythropoietin Drugs Market by Drug Class
        • 6.3.4.3.2 India Erythropoietin Drugs Market by Product
        • 6.3.4.3.3 India Erythropoietin Drugs Market by Application
      • 6.3.4.4 South Korea Erythropoietin Drugs Market
        • 6.3.4.4.1 South Korea Erythropoietin Drugs Market by Drug Class
        • 6.3.4.4.2 South Korea Erythropoietin Drugs Market by Product
        • 6.3.4.4.3 South Korea Erythropoietin Drugs Market by Application
      • 6.3.4.5 Singapore Erythropoietin Drugs Market
        • 6.3.4.5.1 Singapore Erythropoietin Drugs Market by Drug Class
        • 6.3.4.5.2 Singapore Erythropoietin Drugs Market by Product
        • 6.3.4.5.3 Singapore Erythropoietin Drugs Market by Application
      • 6.3.4.6 Malaysia Erythropoietin Drugs Market
        • 6.3.4.6.1 Malaysia Erythropoietin Drugs Market by Drug Class
        • 6.3.4.6.2 Malaysia Erythropoietin Drugs Market by Product
        • 6.3.4.6.3 Malaysia Erythropoietin Drugs Market by Application
      • 6.3.4.7 Rest of Asia Pacific Erythropoietin Drugs Market
        • 6.3.4.7.1 Rest of Asia Pacific Erythropoietin Drugs Market by Drug Class
        • 6.3.4.7.2 Rest of Asia Pacific Erythropoietin Drugs Market by Product
        • 6.3.4.7.3 Rest of Asia Pacific Erythropoietin Drugs Market by Application
  • 6.4 LAMEA Erythropoietin Drugs Market
    • 6.4.1 LAMEA Erythropoietin Drugs Market by Drug Class
      • 6.4.1.1 LAMEA Biologics Market by Country
      • 6.4.1.2 LAMEA Biosimilars Market by Country
    • 6.4.2 LAMEA Erythropoietin Drugs Market by Product
      • 6.4.2.1 LAMEA Epoetin-alfa Market by Country
      • 6.4.2.2 LAMEA Epoetin-beta Market by Country
      • 6.4.2.3 LAMEA Darbepoetin-alfa Market by Country
      • 6.4.2.4 LAMEA Other Product Market by Country
    • 6.4.3 LAMEA Erythropoietin Drugs Market by Application
      • 6.4.3.1 LAMEA Renal Diseases Market by Country
      • 6.4.3.2 LAMEA Cancer Market by Country
      • 6.4.3.3 LAMEA Hematology Market by Country
      • 6.4.3.4 LAMEA Neurology Market by Country
    • 6.4.4 LAMEA Erythropoietin Drugs Market by Country
      • 6.4.4.1 Brazil Erythropoietin Drugs Market
        • 6.4.4.1.1 Brazil Erythropoietin Drugs Market by Drug Class
        • 6.4.4.1.2 Brazil Erythropoietin Drugs Market by Product
        • 6.4.4.1.3 Brazil Erythropoietin Drugs Market by Application
      • 6.4.4.2 Argentina Erythropoietin Drugs Market
        • 6.4.4.2.1 Argentina Erythropoietin Drugs Market by Drug Class
        • 6.4.4.2.2 Argentina Erythropoietin Drugs Market by Product
        • 6.4.4.2.3 Argentina Erythropoietin Drugs Market by Application
      • 6.4.4.3 UAE Erythropoietin Drugs Market
        • 6.4.4.3.1 UAE Erythropoietin Drugs Market by Drug Class
        • 6.4.4.3.2 UAE Erythropoietin Drugs Market by Product
        • 6.4.4.3.3 UAE Erythropoietin Drugs Market by Application
      • 6.4.4.4 Saudi Arabia Erythropoietin Drugs Market
        • 6.4.4.4.1 Saudi Arabia Erythropoietin Drugs Market by Drug Class
        • 6.4.4.4.2 Saudi Arabia Erythropoietin Drugs Market by Product
        • 6.4.4.4.3 Saudi Arabia Erythropoietin Drugs Market by Application
      • 6.4.4.5 South Africa Erythropoietin Drugs Market
        • 6.4.4.5.1 South Africa Erythropoietin Drugs Market by Drug Class
        • 6.4.4.5.2 South Africa Erythropoietin Drugs Market by Product
        • 6.4.4.5.3 South Africa Erythropoietin Drugs Market by Application
      • 6.4.4.6 Nigeria Erythropoietin Drugs Market
        • 6.4.4.6.1 Nigeria Erythropoietin Drugs Market by Drug Class
        • 6.4.4.6.2 Nigeria Erythropoietin Drugs Market by Product
        • 6.4.4.6.3 Nigeria Erythropoietin Drugs Market by Application
      • 6.4.4.7 Rest of LAMEA Erythropoietin Drugs Market
        • 6.4.4.7.1 Rest of LAMEA Erythropoietin Drugs Market by Drug Class
        • 6.4.4.7.2 Rest of LAMEA Erythropoietin Drugs Market by Product
        • 6.4.4.7.3 Rest of LAMEA Erythropoietin Drugs Market by Application

Chapter 7. Company Profiles

  • 7.1 Johnson and Johnson
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental &Regional Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Approvals:
  • 7.2 Teva Pharmaceutical Industries Ltd.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Amgen, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Partnerships, Collaborations, and Agreements:
  • 7.4 F. Hoffmann-La Roche Ltd.
    • 7.4.1 Company Overview
    • 7.4.1 Financial Analysis
    • 7.4.2 Segmental and Regional Analysis
    • 7.4.3 Research & Development Expense
  • 7.5 Biocon Limited
    • 7.5.1 Company Overview
  • 7.6 Intas Pharmaceutical Ltd.
    • 7.6.1 Company Overview
  • 7.7 Sun Pharmaceutical Industries Ltd.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Dr. Reddy's Laboratories Ltd.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 LG Corporation (LG Life Sciences Ltd.)
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
  • 7.10. Celltrion, Inc.
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 2 Global Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 3 Global Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 4 Global Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 5 Global Biologics Market by Region, 2017 - 2020, USD Million
  • TABLE 6 Global Biologics Market by Region, 2021 - 2027, USD Million
  • TABLE 7 Global Biosimilars Market by Region, 2017 - 2020, USD Million
  • TABLE 8 Global Biosimilars Market by Region, 2021 - 2027, USD Million
  • TABLE 9 Global Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 10 Global Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 11 Global Epoetin-alfa Market by Region, 2017 - 2020, USD Million
  • TABLE 12 Global Epoetin-alfa Market by Region, 2021 - 2027, USD Million
  • TABLE 13 Global Epoetin-beta Market by Region, 2017 - 2020, USD Million
  • TABLE 14 Global Epoetin-beta Market by Region, 2021 - 2027, USD Million
  • TABLE 15 Global Darbepoetin-alfa Market by Region, 2017 - 2020, USD Million
  • TABLE 16 Global Darbepoetin-alfa Market by Region, 2021 - 2027, USD Million
  • TABLE 17 Global Other Product Market by Region, 2017 - 2020, USD Million
  • TABLE 18 Global Other Product Market by Region, 2021 - 2027, USD Million
  • TABLE 19 Global Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 20 Global Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 21 Global Renal Diseases Market by Region, 2017 - 2020, USD Million
  • TABLE 22 Global Renal Diseases Market by Region, 2021 - 2027, USD Million
  • TABLE 23 Global Cancer Market by Region, 2017 - 2020, USD Million
  • TABLE 24 Global Cancer Market by Region, 2021 - 2027, USD Million
  • TABLE 25 Global Hematology Market by Region, 2017 - 2020, USD Million
  • TABLE 26 Global Hematology Market by Region, 2021 - 2027, USD Million
  • TABLE 27 Global Neurology Market by Region, 2017 - 2020, USD Million
  • TABLE 28 Global Neurology Market by Region, 2021 - 2027, USD Million
  • TABLE 29 Global Erythropoietin Drugs Market by Region, 2017 - 2020, USD Million
  • TABLE 30 Global Erythropoietin Drugs Market by Region, 2021 - 2027, USD Million
  • TABLE 31 North America Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 32 North America Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 33 North America Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 34 North America Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 35 North America Biologics Market by Country, 2017 - 2020, USD Million
  • TABLE 36 North America Biologics Market by Country, 2021 - 2027, USD Million
  • TABLE 37 North America Biosimilars Market by Country, 2017 - 2020, USD Million
  • TABLE 38 North America Biosimilars Market by Country, 2021 - 2027, USD Million
  • TABLE 39 North America Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 40 North America Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 41 North America Epoetin-alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 42 North America Epoetin-alfa Market by Country, 2021 - 2027, USD Million
  • TABLE 43 North America Epoetin-beta Market by Country, 2017 - 2020, USD Million
  • TABLE 44 North America Epoetin-beta Market by Country, 2021 - 2027, USD Million
  • TABLE 45 North America Darbepoetin-alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 46 North America Darbepoetin-alfa Market by Country, 2021 - 2027, USD Million
  • TABLE 47 North America Other Product Market by Country, 2017 - 2020, USD Million
  • TABLE 48 North America Other Product Market by Country, 2021 - 2027, USD Million
  • TABLE 49 North America Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 50 North America Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 51 North America Renal Diseases Market by Country, 2017 - 2020, USD Million
  • TABLE 52 North America Renal Diseases Market by Country, 2021 - 2027, USD Million
  • TABLE 53 North America Cancer Market by Country, 2017 - 2020, USD Million
  • TABLE 54 North America Cancer Market by Country, 2021 - 2027, USD Million
  • TABLE 55 North America Hematology Market by Country, 2017 - 2020, USD Million
  • TABLE 56 North America Hematology Market by Country, 2021 - 2027, USD Million
  • TABLE 57 North America Neurology Market by Country, 2017 - 2020, USD Million
  • TABLE 58 North America Neurology Market by Country, 2021 - 2027, USD Million
  • TABLE 59 North America Erythropoietin Drugs Market by Country, 2017 - 2020, USD Million
  • TABLE 60 North America Erythropoietin Drugs Market by Country, 2021 - 2027, USD Million
  • TABLE 61 US Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 62 US Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 63 US Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 64 US Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 65 US Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 66 US Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 67 US Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 68 US Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 69 Canada Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 70 Canada Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 71 Canada Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 72 Canada Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 73 Canada Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 74 Canada Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 75 Canada Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 76 Canada Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 77 Mexico Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 78 Mexico Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 79 Mexico Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 80 Mexico Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 81 Mexico Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 82 Mexico Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 83 Mexico Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 84 Mexico Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 85 Rest of North America Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 86 Rest of North America Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 87 Rest of North America Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 88 Rest of North America Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 89 Rest of North America Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 90 Rest of North America Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 91 Rest of North America Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 92 Rest of North America Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 93 Europe Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 94 Europe Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 95 Europe Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 96 Europe Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 97 Europe Biologics Market by Country, 2017 - 2020, USD Million
  • TABLE 98 Europe Biologics Market by Country, 2021 - 2027, USD Million
  • TABLE 99 Europe Biosimilars Market by Country, 2017 - 2020, USD Million
  • TABLE 100 Europe Biosimilars Market by Country, 2021 - 2027, USD Million
  • TABLE 101 Europe Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 102 Europe Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 103 Europe Epoetin-alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 104 Europe Epoetin-alfa Market by Country, 2021 - 2027, USD Million
  • TABLE 105 Europe Epoetin-beta Market by Country, 2017 - 2020, USD Million
  • TABLE 106 Europe Epoetin-beta Market by Country, 2021 - 2027, USD Million
  • TABLE 107 Europe Darbepoetin-alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 108 Europe Darbepoetin-alfa Market by Country, 2021 - 2027, USD Million
  • TABLE 109 Europe Other Product Market by Country, 2017 - 2020, USD Million
  • TABLE 110 Europe Other Product Market by Country, 2021 - 2027, USD Million
  • TABLE 111 Europe Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 112 Europe Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 113 Europe Renal Diseases Market by Country, 2017 - 2020, USD Million
  • TABLE 114 Europe Renal Diseases Market by Country, 2021 - 2027, USD Million
  • TABLE 115 Europe Cancer Market by Country, 2017 - 2020, USD Million
  • TABLE 116 Europe Cancer Market by Country, 2021 - 2027, USD Million
  • TABLE 117 Europe Hematology Market by Country, 2017 - 2020, USD Million
  • TABLE 118 Europe Hematology Market by Country, 2021 - 2027, USD Million
  • TABLE 119 Europe Neurology Market by Country, 2017 - 2020, USD Million
  • TABLE 120 Europe Neurology Market by Country, 2021 - 2027, USD Million
  • TABLE 121 Europe Erythropoietin Drugs Market by Country, 2017 - 2020, USD Million
  • TABLE 122 Europe Erythropoietin Drugs Market by Country, 2021 - 2027, USD Million
  • TABLE 123 Germany Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 124 Germany Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 125 Germany Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 126 Germany Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 127 Germany Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 128 Germany Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 129 Germany Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 130 Germany Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 131 UK Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 132 UK Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 133 UK Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 134 UK Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 135 UK Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 136 UK Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 137 UK Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 138 UK Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 139 France Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 140 France Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 141 France Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 142 France Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 143 France Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 144 France Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 145 France Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 146 France Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 147 Russia Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 148 Russia Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 149 Russia Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 150 Russia Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 151 Russia Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 152 Russia Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 153 Russia Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 154 Russia Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 155 Spain Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 156 Spain Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 157 Spain Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 158 Spain Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 159 Spain Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 160 Spain Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 161 Spain Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 162 Spain Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 163 Italy Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 164 Italy Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 165 Italy Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 166 Italy Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 167 Italy Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 168 Italy Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 169 Italy Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 170 Italy Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 171 Rest of Europe Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 172 Rest of Europe Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 173 Rest of Europe Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 174 Rest of Europe Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 175 Rest of Europe Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 176 Rest of Europe Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 177 Rest of Europe Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 178 Rest of Europe Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 179 Asia Pacific Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 180 Asia Pacific Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 181 Asia Pacific Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 182 Asia Pacific Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 183 Asia Pacific Biologics Market by Country, 2017 - 2020, USD Million
  • TABLE 184 Asia Pacific Biologics Market by Country, 2021 - 2027, USD Million
  • TABLE 185 Asia Pacific Biosimilars Market by Country, 2017 - 2020, USD Million
  • TABLE 186 Asia Pacific Biosimilars Market by Country, 2021 - 2027, USD Million
  • TABLE 187 Asia Pacific Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 188 Asia Pacific Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 189 Asia Pacific Epoetin-alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 190 Asia Pacific Epoetin-alfa Market by Country, 2021 - 2027, USD Million
  • TABLE 191 Asia Pacific Epoetin-beta Market by Country, 2017 - 2020, USD Million
  • TABLE 192 Asia Pacific Epoetin-beta Market by Country, 2021 - 2027, USD Million
  • TABLE 193 Asia Pacific Darbepoetin-alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 194 Asia Pacific Darbepoetin-alfa Market by Country, 2021 - 2027, USD Million
  • TABLE 195 Asia Pacific Other Product Market by Country, 2017 - 2020, USD Million
  • TABLE 196 Asia Pacific Other Product Market by Country, 2021 - 2027, USD Million
  • TABLE 197 Asia Pacific Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 198 Asia Pacific Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 199 Asia Pacific Renal Diseases Market by Country, 2017 - 2020, USD Million
  • TABLE 200 Asia Pacific Renal Diseases Market by Country, 2021 - 2027, USD Million
  • TABLE 201 Asia Pacific Cancer Market by Country, 2017 - 2020, USD Million
  • TABLE 202 Asia Pacific Cancer Market by Country, 2021 - 2027, USD Million
  • TABLE 203 Asia Pacific Hematology Market by Country, 2017 - 2020, USD Million
  • TABLE 204 Asia Pacific Hematology Market by Country, 2021 - 2027, USD Million
  • TABLE 205 Asia Pacific Neurology Market by Country, 2017 - 2020, USD Million
  • TABLE 206 Asia Pacific Neurology Market by Country, 2021 - 2027, USD Million
  • TABLE 207 Asia Pacific Erythropoietin Drugs Market by Country, 2017 - 2020, USD Million
  • TABLE 208 Asia Pacific Erythropoietin Drugs Market by Country, 2021 - 2027, USD Million
  • TABLE 209 China Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 210 China Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 211 China Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 212 China Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 213 China Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 214 China Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 215 China Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 216 China Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 217 Japan Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 218 Japan Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 219 Japan Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 220 Japan Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 221 Japan Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 222 Japan Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 223 Japan Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 224 Japan Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 225 India Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 226 India Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 227 India Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 228 India Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 229 India Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 230 India Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 231 India Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 232 India Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 233 South Korea Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 234 South Korea Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 235 South Korea Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 236 South Korea Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 237 South Korea Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 238 South Korea Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 239 South Korea Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 240 South Korea Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 241 Singapore Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 242 Singapore Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 243 Singapore Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 244 Singapore Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 245 Singapore Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 246 Singapore Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 247 Singapore Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 248 Singapore Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 249 Malaysia Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 250 Malaysia Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 251 Malaysia Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 252 Malaysia Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 253 Malaysia Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 254 Malaysia Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 255 Malaysia Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 256 Malaysia Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 257 Rest of Asia Pacific Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 258 Rest of Asia Pacific Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 259 Rest of Asia Pacific Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 260 Rest of Asia Pacific Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 261 Rest of Asia Pacific Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 262 Rest of Asia Pacific Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 263 Rest of Asia Pacific Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 264 Rest of Asia Pacific Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 265 LAMEA Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 266 LAMEA Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 267 LAMEA Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 268 LAMEA Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 269 LAMEA Biologics Market by Country, 2017 - 2020, USD Million
  • TABLE 270 LAMEA Biologics Market by Country, 2021 - 2027, USD Million
  • TABLE 271 LAMEA Biosimilars Market by Country, 2017 - 2020, USD Million
  • TABLE 272 LAMEA Biosimilars Market by Country, 2021 - 2027, USD Million
  • TABLE 273 LAMEA Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 274 LAMEA Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 275 LAMEA Epoetin-alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 276 LAMEA Epoetin-alfa Market by Country, 2021 - 2027, USD Million
  • TABLE 277 LAMEA Epoetin-beta Market by Country, 2017 - 2020, USD Million
  • TABLE 278 LAMEA Epoetin-beta Market by Country, 2021 - 2027, USD Million
  • TABLE 279 LAMEA Darbepoetin-alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 280 LAMEA Darbepoetin-alfa Market by Country, 2021 - 2027, USD Million
  • TABLE 281 LAMEA Other Product Market by Country, 2017 - 2020, USD Million
  • TABLE 282 LAMEA Other Product Market by Country, 2021 - 2027, USD Million
  • TABLE 283 LAMEA Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 284 LAMEA Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 285 LAMEA Renal Diseases Market by Country, 2017 - 2020, USD Million
  • TABLE 286 LAMEA Renal Diseases Market by Country, 2021 - 2027, USD Million
  • TABLE 287 LAMEA Cancer Market by Country, 2017 - 2020, USD Million
  • TABLE 288 LAMEA Cancer Market by Country, 2021 - 2027, USD Million
  • TABLE 289 LAMEA Hematology Market by Country, 2017 - 2020, USD Million
  • TABLE 290 LAMEA Hematology Market by Country, 2021 - 2027, USD Million
  • TABLE 291 LAMEA Neurology Market by Country, 2017 - 2020, USD Million
  • TABLE 292 LAMEA Neurology Market by Country, 2021 - 2027, USD Million
  • TABLE 293 LAMEA Erythropoietin Drugs Market by Country, 2017 - 2020, USD Million
  • TABLE 294 LAMEA Erythropoietin Drugs Market by Country, 2021 - 2027, USD Million
  • TABLE 295 Brazil Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 296 Brazil Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 297 Brazil Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 298 Brazil Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 299 Brazil Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 300 Brazil Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 301 Brazil Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 302 Brazil Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 303 Argentina Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 304 Argentina Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 305 Argentina Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 306 Argentina Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 307 Argentina Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 308 Argentina Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 309 Argentina Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 310 Argentina Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 311 UAE Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 312 UAE Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 313 UAE Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 314 UAE Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 315 UAE Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 316 UAE Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 317 UAE Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 318 UAE Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 319 Saudi Arabia Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 320 Saudi Arabia Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 321 Saudi Arabia Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 322 Saudi Arabia Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 323 Saudi Arabia Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 324 Saudi Arabia Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 325 Saudi Arabia Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 326 Saudi Arabia Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 327 South Africa Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 328 South Africa Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 329 South Africa Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 330 South Africa Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 331 South Africa Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 332 South Africa Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 333 South Africa Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 334 South Africa Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 335 Nigeria Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 336 Nigeria Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 337 Nigeria Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 338 Nigeria Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 339 Nigeria Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 340 Nigeria Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 341 Nigeria Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 342 Nigeria Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 343 Rest of LAMEA Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 344 Rest of LAMEA Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 345 Rest of LAMEA Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 346 Rest of LAMEA Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 347 Rest of LAMEA Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 348 Rest of LAMEA Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 349 Rest of LAMEA Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 350 Rest of LAMEA Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 351 Key information -Johnson and Johnson
  • TABLE 352 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 353 Key Information - Amgen, Inc.
  • TABLE 354 key information - F. Hoffmann-La Roche Ltd.
  • TABLE 355 Key Information - Biocon Limited
  • TABLE 356 Key Information - Intas Pharmaceutical Ltd.
  • TABLE 357 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 358 key information - Dr. Reddy's Laboratories Ltd.
  • TABLE 359 Key Information - LG Corporation
  • TABLE 360 key information - Celltrion, Inc.

List of Figures

  • FIG 1 Methodology for the research